Showing results (291-300 of 469) with videos related to
Sort By:
Pageof 47
Journal of Acquired Immune Deficiency Syndromes (1999)|July 22, 2020
Anogenital Human Papillomavirus and HIV Infection in Rwandan Men Who Have Sex With MenGad Murenzi, Hae-Young Kim, Athanase Munyaneza, et al.The Lancet. Oncology|May 2, 2024
Considerations for using potential surrogate endpoints in cancer screening trialsAlexis B Webb, Christine D Berg, Philip E Castle, et al.Gynecologic Oncology Reports|March 25, 2017
Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income countryMauricio Maza, Karla Alfaro, Jillian Garai, et al.Journal of Lower Genital Tract Disease|March 23, 2013
Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positiveHormuzd A Katki, Mark Schiffman, Philip E Castle, et al.Journal of Lower Genital Tract Disease|March 23, 2013
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 yearsHormuzd A Katki, Mark Schiffman, Philip E Castle, et al.International Journal of Cancer|August 11, 2024
Cancer risk among people living with Human Immunodeficiency Virus (HIV) in Rwanda from 2007 to 2018Jean Claude Dusingize, Gad Murenzi, Benjamin Muhoza, et al.Journal of Lower Genital Tract Disease|September 28, 2017
Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening GuidelinesMaria Demarco, Thomas S Lorey, Barbara Fetterman, et al.Gynecologic Oncology|February 27, 2016
A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test resultsMichelle J Khan, L Stewart Massad, Walter Kinney, et al.Journal of Lower Genital Tract Disease|February 19, 2016
Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El SalvadorMiriam L Cremer, Mauricio Maza, Karla M Alfaro, et al.African Journal of Laboratory Medicine|November 10, 2022
Agreement between Xpert and AmpFire tests for high-risk human papillomavirus among HIV-positive women in RwandaAnthere Murangwa, Kanan T Desai, Julia C Gage, et al.Pageof 47